1
|
Gene Therapy for Regenerative Medicine. Pharmaceutics 2023; 15:pharmaceutics15030856. [PMID: 36986717 PMCID: PMC10057434 DOI: 10.3390/pharmaceutics15030856] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 02/24/2023] [Accepted: 03/01/2023] [Indexed: 03/08/2023] Open
Abstract
The development of biological methods over the past decade has stimulated great interest in the possibility to regenerate human tissues. Advances in stem cell research, gene therapy, and tissue engineering have accelerated the technology in tissue and organ regeneration. However, despite significant progress in this area, there are still several technical issues that must be addressed, especially in the clinical use of gene therapy. The aims of gene therapy include utilising cells to produce a suitable protein, silencing over-producing proteins, and genetically modifying and repairing cell functions that may affect disease conditions. While most current gene therapy clinical trials are based on cell- and viral-mediated approaches, non-viral gene transfection agents are emerging as potentially safe and effective in the treatment of a wide variety of genetic and acquired diseases. Gene therapy based on viral vectors may induce pathogenicity and immunogenicity. Therefore, significant efforts are being invested in non-viral vectors to enhance their efficiency to a level comparable to the viral vector. Non-viral technologies consist of plasmid-based expression systems containing a gene encoding, a therapeutic protein, and synthetic gene delivery systems. One possible approach to enhance non-viral vector ability or to be an alternative to viral vectors would be to use tissue engineering technology for regenerative medicine therapy. This review provides a critical view of gene therapy with a major focus on the development of regenerative medicine technologies to control the in vivo location and function of administered genes.
Collapse
|
2
|
Saberi Riseh R, Hassanisaadi M, Vatankhah M, Soroush F, Varma RS. Nano/microencapsulation of plant biocontrol agents by chitosan, alginate, and other important biopolymers as a novel strategy for alleviating plant biotic stresses. Int J Biol Macromol 2022; 222:1589-1604. [DOI: 10.1016/j.ijbiomac.2022.09.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 09/19/2022] [Accepted: 09/28/2022] [Indexed: 11/05/2022]
|
3
|
El Kheir W, Marcos B, Virgilio N, Paquette B, Faucheux N, Lauzon MA. Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment. Pharmaceutics 2022; 14:1189. [PMID: 35745762 PMCID: PMC9227363 DOI: 10.3390/pharmaceutics14061189] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2022] [Revised: 05/25/2022] [Accepted: 05/30/2022] [Indexed: 02/04/2023] Open
Abstract
Glioblastoma multiforme (GBM) is a grade IV glioma considered the most fatal cancer of the central nervous system (CNS), with less than a 5% survival rate after five years. The tumor heterogeneity, the high infiltrative behavior of its cells, and the blood-brain barrier (BBB) that limits the access of therapeutic drugs to the brain are the main reasons hampering the current standard treatment efficiency. Following the tumor resection, the infiltrative remaining GBM cells, which are resistant to chemotherapy and radiotherapy, can further invade the surrounding brain parenchyma. Consequently, the development of new strategies to treat parenchyma-infiltrating GBM cells, such as vaccines, nanotherapies, and tumor cells traps including drug delivery systems, is required. For example, the chemoattractant CXCL12, by binding to its CXCR4 receptor, activates signaling pathways that play a critical role in tumor progression and invasion, making it an interesting therapeutic target to properly control the direction of GBM cell migration for treatment proposes. Moreover, the interstitial fluid flow (IFF) is also implicated in increasing the GBM cell migration through the activation of the CXCL12-CXCR4 signaling pathway. However, due to its complex and variable nature, the influence of the IFF on the efficiency of drug delivery systems is not well understood yet. Therefore, this review discusses novel drug delivery strategies to overcome the GBM treatment limitations, focusing on chemokines such as CXCL12 as an innovative approach to reverse the migration of infiltrated GBM. Furthermore, recent developments regarding in vitro 3D culture systems aiming to mimic the dynamic peritumoral environment for the optimization of new drug delivery technologies are highlighted.
Collapse
Affiliation(s)
- Wiam El Kheir
- Advanced Dynamic Cell Culture Systems Laboratory, Department of Chemical Engineering and Biotechnology Engineering, Faculty of Engineering, Université de Sherbrooke, 2500 Boul. Université, Sherbrooke, QC J1K 2R1, Canada;
- Laboratory of Cell-Biomaterial Biohybrid Systems, Department of Chemical Engineering and Biotechnology Engineering, Faculty of Engineering, Université de Sherbrooke, 2500 Boul. Université, Sherbrooke, QC J1K 2R1, Canada;
| | - Bernard Marcos
- Department of Chemical Engineering and Biotechnology Engineering, Faculty of Engineering, Université de Sherbrooke, 2500 Boul. Université, Sherbrooke, QC J1K 2R1, Canada;
| | - Nick Virgilio
- Department of Chemical Engineering, Polytechnique Montréal, 2500 Chemin de Polytechnique, Montréal, QC H3T 1J4, Canada;
| | - Benoit Paquette
- Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada;
- Clinical Research Center of the Centre Hospitalier Universitaire de l’Université de Sherbrooke, 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada
| | - Nathalie Faucheux
- Laboratory of Cell-Biomaterial Biohybrid Systems, Department of Chemical Engineering and Biotechnology Engineering, Faculty of Engineering, Université de Sherbrooke, 2500 Boul. Université, Sherbrooke, QC J1K 2R1, Canada;
- Clinical Research Center of the Centre Hospitalier Universitaire de l’Université de Sherbrooke, 12e Avenue Nord, Sherbrooke, QC J1H 5N4, Canada
| | - Marc-Antoine Lauzon
- Advanced Dynamic Cell Culture Systems Laboratory, Department of Chemical Engineering and Biotechnology Engineering, Faculty of Engineering, Université de Sherbrooke, 2500 Boul. Université, Sherbrooke, QC J1K 2R1, Canada;
- Research Center on Aging, 1036 Rue Belvédère Sud, Sherbrooke, QC J1H 4C4, Canada
| |
Collapse
|
4
|
|
5
|
|
6
|
Ali A, Ijaz M, Khan YR, Sajid HA, Hussain K, Rabbani AH, Shahid M, Naseer O, Ghaffar A, Naeem MA, Zafar MZ, Malik AI, Ahmed I. Role of nanotechnology in animal production and veterinary medicine. Trop Anim Health Prod 2021; 53:508. [PMID: 34626253 DOI: 10.1007/s11250-021-02951-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2021] [Accepted: 09/30/2021] [Indexed: 11/26/2022]
Abstract
Nanotechnology is the discipline and technology of small and specific things that are < 100 nm in size. Because of their extremely miniscule size, any changes in their chemical and physical structure may show higher reactivity and solubility than larger particles. Nanotechnology plays a vital role in every field of life. It is considered one of the most bleeding edge field of scientific research. It has already several applications in a myriad of disciplines while its application in the field of animal production and veterinary medicine is still experimental in nature. But, in recent years, the role of nanotechnology in the aforementioned fields of scientific inquiry has shown great progress. These days, nanotechnology has been employed to revolutionize drug delivery systems and diagnose atypical diseases. Applications of nanoparticle technology in the field of animal reproduction and development of efficacious vaccines have been at the forefront of scientific endeavors. Additionally, their impacts on meat and milk quality are also being judiciously inquired in recent decades. Veterinary nanotechnology has great potential to improve diagnosis and treatment, and provide new tools to this field. This review focuses on some noteworthy applications of nanoparticles in the field of animal production and their future perspectives.
Collapse
Affiliation(s)
- Ahmad Ali
- Department of Medicine, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan.
| | - Muhammad Ijaz
- Department of Veterinary Medicine, University of Veterinary and Animal Sciences, Lahore, Pakistan
| | - Yasir Razzaq Khan
- Department of Medicine, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan
| | - Hina Afzal Sajid
- Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
| | - Kashif Hussain
- Department of Medicine, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan
| | - Ameer Hamza Rabbani
- Department of Surgery, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan
| | - Muhammad Shahid
- Department of Surgery, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan
| | - Omer Naseer
- Department of Medicine, Cholistan University of Veterinary and Animal Sciences, Bahawalpur, Pakistan
| | - Awais Ghaffar
- Department of Clinical Sciences, KBCMA, College of Veterinary and Animal Sciences, Narowal, Pakistan
| | - Muhammad Anas Naeem
- Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan
| | - Muhammad Zeeshan Zafar
- Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan
| | - Amir Iftikhar Malik
- Department of Clinical Medicine and Surgery, Faculty of Veterinary & Animal Sciences, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
| | - Irfan Ahmed
- Department of Animal Nutrition, Faculty of Veterinary & Animal Sciences, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
| |
Collapse
|
7
|
Gondim DR, Cecilia JA, Rodrigues TNB, Vilarrasa-García E, Rodríguez-Castellón E, Azevedo DCS, Silva IJ. Protein Adsorption onto Modified Porous Silica by Single and Binary Human Serum Protein Solutions. Int J Mol Sci 2021; 22:9164. [PMID: 34502072 PMCID: PMC8430731 DOI: 10.3390/ijms22179164] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Revised: 08/16/2021] [Accepted: 08/21/2021] [Indexed: 12/17/2022] Open
Abstract
Typical porous silica (SBA-15) has been modified with pore expander agent (1,3,5-trimethylbenzene) and fluoride-species to diminish the length of the channels to obtain materials with different textural properties, varying the Si/Zr molar ratio between 20 and 5. These porous materials were characterized by X-ray Diffraction (XRD), N2 adsorption/desorption isotherms at -196 °C and X-ray Photoelectron Spectroscopy (XPS), obtaining adsorbent with a surface area between 420-337 m2 g-1 and an average pore diameter with a maximum between 20-25 nm. These materials were studied in the adsorption of human blood serum proteins (human serum albumin-HSA and immunoglobulin G-IgG). Generally, the incorporation of small proportions was favorable for proteins adsorption. The adsorption data revealed that the maximum adsorption capacity was reached close to the pI. The batch purification experiments in binary human serum solutions showed that Si sample has considerable adsorption for IgG while HSA adsorption is relatively low, so it is possible its separation.
Collapse
Affiliation(s)
- Diego R. Gondim
- Centro de Tecnologia, Grupo de Pesquisa em Separações por Adsorção—GPSA—Departamento de Engenharia Química, Campus do Pici, Bl. 709, Universidade Federal do Ceará, Fortaleza 60455-760, CE, Brazil; (D.R.G.); (T.N.B.R.); (E.V.-G.); (D.C.S.A.); (I.J.S.J.)
| | - Juan A. Cecilia
- Departamento de Química Inorgánica, Cristalografía y Mineralogía, Facultad de Ciencias, Campus de Teatinos, Universidad de Málaga, 29071 Malaga, Spain;
| | - Thaina N. B. Rodrigues
- Centro de Tecnologia, Grupo de Pesquisa em Separações por Adsorção—GPSA—Departamento de Engenharia Química, Campus do Pici, Bl. 709, Universidade Federal do Ceará, Fortaleza 60455-760, CE, Brazil; (D.R.G.); (T.N.B.R.); (E.V.-G.); (D.C.S.A.); (I.J.S.J.)
| | - Enrique Vilarrasa-García
- Centro de Tecnologia, Grupo de Pesquisa em Separações por Adsorção—GPSA—Departamento de Engenharia Química, Campus do Pici, Bl. 709, Universidade Federal do Ceará, Fortaleza 60455-760, CE, Brazil; (D.R.G.); (T.N.B.R.); (E.V.-G.); (D.C.S.A.); (I.J.S.J.)
| | - Enrique Rodríguez-Castellón
- Departamento de Química Inorgánica, Cristalografía y Mineralogía, Facultad de Ciencias, Campus de Teatinos, Universidad de Málaga, 29071 Malaga, Spain;
| | - Diana C. S. Azevedo
- Centro de Tecnologia, Grupo de Pesquisa em Separações por Adsorção—GPSA—Departamento de Engenharia Química, Campus do Pici, Bl. 709, Universidade Federal do Ceará, Fortaleza 60455-760, CE, Brazil; (D.R.G.); (T.N.B.R.); (E.V.-G.); (D.C.S.A.); (I.J.S.J.)
| | - Ivanildo J. Silva
- Centro de Tecnologia, Grupo de Pesquisa em Separações por Adsorção—GPSA—Departamento de Engenharia Química, Campus do Pici, Bl. 709, Universidade Federal do Ceará, Fortaleza 60455-760, CE, Brazil; (D.R.G.); (T.N.B.R.); (E.V.-G.); (D.C.S.A.); (I.J.S.J.)
| |
Collapse
|
8
|
Saberi-Riseh R, Moradi-Pour M, Mohammadinejad R, Thakur VK. Biopolymers for Biological Control of Plant Pathogens: Advances in Microencapsulation of Beneficial Microorganisms. Polymers (Basel) 2021; 13:1938. [PMID: 34200966 PMCID: PMC8230584 DOI: 10.3390/polym13121938] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2021] [Revised: 05/29/2021] [Accepted: 06/01/2021] [Indexed: 12/17/2022] Open
Abstract
The use of biofertilizers, including biocontrol agents such as Pseudomonas and Bacillus in agriculture can increase soil characteristics and plant acquisition of nutrients and enhancement the efficiency of manure and mineral fertilizer. Despite the problems that liquid and solid formulations have in maintaining the viability of microbial agents, encapsulation can improve their application with extended shelf-life, and controlled release from formulations. Research into novel formulation methods especially encapsulation techniques has increased in recent years due to the mounting demand for microbial biological control. The application of polymeric materials in agriculture has developed recently as a replacement for traditional materials and considered an improvement in technological processes in the growing of crops. This study aims to overview of types of biopolymers and methods used for encapsulation of living biological control agents, especially microbial organisms.
Collapse
Affiliation(s)
- Roohallah Saberi-Riseh
- Department of Plant Protection, Faculty of Agriculture, Vali-e-Asr University of Rafsanjan, Rafsanjan 7718893514, Iran;
| | - Mojde Moradi-Pour
- Department of Plant Protection, Faculty of Agriculture, Vali-e-Asr University of Rafsanjan, Rafsanjan 7718893514, Iran;
| | - Reza Mohammadinejad
- Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman 7618866749, Iran;
| | - Vijay Kumar Thakur
- Biorefining and Advanced Materials Research Center, Scotland’s Rural College (SRUC), Kings Buildings, West Mains Road, Edinburgh EH9 3JG, UK
| |
Collapse
|
9
|
Perrelli A, Fatehbasharzad P, Benedetti V, Ferraris C, Fontanella M, De Luca E, Moglianetti M, Battaglia L, Retta SF. Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opin Drug Deliv 2021; 18:849-876. [PMID: 33406376 DOI: 10.1080/17425247.2021.1873273] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Introduction: Cerebrovascular diseases encompass various disorders of the brain vasculature, such as ischemic/hemorrhagic strokes, aneurysms, and vascular malformations, also affecting the central nervous system leading to a large variety of transient or permanent neurological disorders. They represent major causes of mortality and long-term disability worldwide, and some of them can be inherited, including Cerebral Cavernous Malformation (CCM), an autosomal dominant cerebrovascular disease linked to mutations in CCM1/KRIT1, CCM2, or CCM3/PDCD10 genes.Areas covered: Besides marked clinical and etiological heterogeneity, some commonalities are emerging among distinct cerebrovascular diseases, including key pathogenetic roles of oxidative stress and inflammation, which are increasingly recognized as major disease hallmarks and therapeutic targets. This review provides a comprehensive overview of the different clinical features and common pathogenetic determinants of cerebrovascular diseases, highlighting major challenges, including the pressing need for new diagnostic and therapeutic strategies, and focusing on emerging innovative features and promising benefits of nanomedicine strategies for early detection and targeted treatment of such diseases.Expert opinion: Specifically, we describe and discuss the multiple physico-chemical features and unique biological advantages of nanosystems, including nanodiagnostics, nanotherapeutics, and nanotheranostics, that may help improving diagnosis and treatment of cerebrovascular diseases and neurological comorbidities, with an emphasis on CCM disease.
Collapse
Affiliation(s)
- Andrea Perrelli
- Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy.,CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy
| | - Parisa Fatehbasharzad
- Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy.,CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy
| | - Valerio Benedetti
- Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy.,CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy
| | - Chiara Ferraris
- Department of Drug Science and Technology, University of Torino, Torino, Italy.,Nanostructured Interfaces and Surfaces (NIS) Interdepartmental Centre, University of Torino, Torino, Italy
| | - Marco Fontanella
- CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy.,Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
| | - Elisa De Luca
- Nanobiointeractions & Nanodiagnostics, Center for Biomolecular Nanotechnologies, Arnesano, Lecce, Italy.,Institute for Microelectronics and Microsystems (IMM), CNR, Lecce, Italy
| | - Mauro Moglianetti
- Nanobiointeractions & Nanodiagnostics, Center for Biomolecular Nanotechnologies, Arnesano, Lecce, Italy.,Istituto Italiano Di Tecnologia, Nanobiointeractions & Nanodiagnostics, Genova, Italy
| | - Luigi Battaglia
- Department of Drug Science and Technology, University of Torino, Torino, Italy.,Nanostructured Interfaces and Surfaces (NIS) Interdepartmental Centre, University of Torino, Torino, Italy
| | - Saverio Francesco Retta
- Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy.,CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, Orbassano, Torino Italy
| |
Collapse
|
10
|
Tong X, Pan W, Su T, Zhang M, Dong W, Qi X. Recent advances in natural polymer-based drug delivery systems. REACT FUNCT POLYM 2020. [DOI: 10.1016/j.reactfunctpolym.2020.104501] [Citation(s) in RCA: 58] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
11
|
Ranpise HA, Gujar KN, Pawar SC, Awasthi R, Dua K, Mathure D, Madan JR. Formulation, Optimization, and Evaluation of Ketoconazole Loaded Nanostructured Lipid Carrier Gel for Topical Delivery. ACTA ACUST UNITED AC 2020. [DOI: 10.2174/2210303109666190717155731] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Objective:
Ketoconazole is used in the treatment of superficial and systemic fungal infections.
It acts by blocking the synthesis of ergosterol, an essential component of the fungal cell membrane.
The purpose of this work was to formulate ketoconazole loaded nanostructured lipid carriers
formulation for skin targeting to minimize the adverse side effects and to prolong release.
Methods:
The ketoconazole loaded nanostructured lipid carriers were optimized using 32 factorial design
to evaluate the effects of process and formulation variables. The nanostructured lipid carriers were
prepared by melt-dispersion ultra-sonication method. The formulations were finally incorporated into
polymeric gels of Carbopol 940 for convenient application. The gels were evaluated comparatively
with commercially available formulations of ketoconazole with respect to ex vivo skin permeation and
deposition study on human cadaver skin.
Results:
Nanostructured lipid carriers showed average particle size, zeta potential, and percentage entrapment
in the range of 125.8 ± 1.8 to 295.0 ± 3.8 nm, -13.2 ± 1.1 to -30.9 ± 2.2 mV, and 69.47 ± 2.8
to 95.49 ± 4.5, respectively. Thermal studies revealed no drug-excipient incompatibility and amorphization
of ketoconazole. Ex vivo study of the gel exhibited prolonged drug release up to 12 h. In vitro
drug deposition study showed that the gel formulation can avoid the systemic uptake, better accumulative
uptake of the drug, and nonirritant to the skin compared to marketed formulation. Optimized formulation
exhibited better antifungal activity when compared to ketoconazole loaded gel and marketed
cream (Keto ® cream). Histolopathology results indicated no toxic effect on the skin.
Conclusion:
These results indicate that developed nanostructured lipid-carriers gel formulation represents
a promising carrier for topical delivery of ketoconazole, having controlled drug release, and potential
of skin targeting.
Collapse
Affiliation(s)
- Hemant A. Ranpise
- Department of Pharmaceutics, Sinhgad College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India
| | - Kishore N. Gujar
- Department of Pharmaceutics, Sinhgad College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India
| | - Sachin C. Pawar
- Department of Pharmaceutics, Sinhgad College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India
| | - Rajendra Awasthi
- Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida 201313, India
| | - Kamal Dua
- Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo NSW 2007, Australia
| | - Dyandevi Mathure
- Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India
| | - Jyotsana R. Madan
- Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Savitribai Phule Pune University, Pune, Maharashtra, India
| |
Collapse
|
12
|
Kommineni N, Pandi P, Chella N, Domb AJ, Khan W. Antibody drug conjugates: Development, characterization, and regulatory considerations. POLYM ADVAN TECHNOL 2019. [DOI: 10.1002/pat.4789] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Nagavendra Kommineni
- Department of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER) Hyderabad India
| | - Palpandi Pandi
- Department of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER) Hyderabad India
| | - Naveen Chella
- Department of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER) Hyderabad India
| | - Abraham J. Domb
- School of Pharmacy‐ Faculty of MedicineThe Hebrew University of Jerusalem Jerusalem Israel
| | - Wahid Khan
- Department of PharmaceuticsNational Institute of Pharmaceutical Education and Research (NIPER) Hyderabad India
| |
Collapse
|
13
|
Hosseinkhani H, Domb AJ. Biodegradable polymers in gene‐silencing technology. POLYM ADVAN TECHNOL 2019. [DOI: 10.1002/pat.4713] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Affiliation(s)
| | - Abraham J. Domb
- School of Pharmacy‐Faculty of Medicine, Institute of Drug Research, The Center for Nanoscience and Nanotechnology and Alex Grass Center for drug Design and SynthesisThe Hebrew University of Jerusalem Jerusalem Israel
| |
Collapse
|
14
|
Sharma G, Sharma AR, Lee SS, Bhattacharya M, Nam JS, Chakraborty C. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm 2019; 559:360-372. [DOI: 10.1016/j.ijpharm.2019.01.056] [Citation(s) in RCA: 101] [Impact Index Per Article: 20.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Revised: 01/31/2019] [Accepted: 01/31/2019] [Indexed: 01/13/2023]
|
15
|
Abedini F, Ebrahimi M, Roozbehani AH, Domb AJ, Hosseinkhani H. Overview on natural hydrophilic polysaccharide polymers in drug delivery. POLYM ADVAN TECHNOL 2018. [DOI: 10.1002/pat.4375] [Citation(s) in RCA: 80] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Fatemeh Abedini
- Agricultural Research, Education, and Extension Organization; Razi Vaccine and Serum Research Institute; Hesarak Karaj Alborz Iran
| | - Mohammad Ebrahimi
- Agricultural Research, Education, and Extension Organization; Razi Vaccine and Serum Research Institute; Hesarak Karaj Alborz Iran
| | | | - Abraham J. Domb
- School of Pharmacy-Faculty of Medicine, Institute of Drug Research, The Center for Nanoscience and Nanotechnology and Alex Grass Center for drug Design and Synthesis, School of Pharmacy-Faculty of Medicine; The Hebrew University of Jerusalem; Jerusalem 91120 Israel
| | | |
Collapse
|
16
|
Jiang Z, Tian Y, Shan D, Wang Y, Gerhard E, Xia J, Huang R, He Y, Li A, Tang J, Ruan H, Li Y, Li J, Yang J, Wu A. pH protective Y1 receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and therapy with prolonged survival time. Biomaterials 2018; 170:70-81. [DOI: 10.1016/j.biomaterials.2018.04.002] [Citation(s) in RCA: 34] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2018] [Revised: 03/28/2018] [Accepted: 04/01/2018] [Indexed: 12/18/2022]
|
17
|
Tarvirdipour S, Vasheghani-Farahani E, Soleimani M, Bardania H. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells. Int J Pharm 2016; 501:331-41. [PMID: 26875475 DOI: 10.1016/j.ijpharm.2016.02.012] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2015] [Revised: 02/06/2016] [Accepted: 02/08/2016] [Indexed: 12/25/2022]
Abstract
In recent decades, targeted drug delivery systems for breast cancer treatment emerged as an ideal alternative and promising solution to reduce systemic side effects of chemotherapeutic agents. In this study, the preparation and characterization of cationic doxorubicin (DOX) loaded magnetic dextran-spermine (DEX-SP) nanocarriers (DEX-SP-DOX) by ionic gelation were fully investigated. Then, anti-HER2 as a monoclonal antibody (mAb) and targeting ligand was conjugated via EDC/NHS reagents. The binding was confirmed by Bradford assay and further assessments were carried out by size and zeta potential measurements. Cytotoxicity effect and internalization of magnetic nanocarriers were assessed by MTT and Prussian blue assays and transmission electron microscopy (TEM), respectively. DLS measurements indicated that the size of nanocarriers increased from 62 to 84 nm by conjugation of anti-HER2 to them. The in vitro release of DOX from mAb conjugated magnetic nanocarriers at pHs 5 and 7.4 was found to be 85 and 55.5%, respectively. The MTT and Prussian blue assays demonstrated enhanced and selective uptake of DEX-SP-DOX-mAb by SKBR cell (HER2 overexpressed cells) in comparison with unconjugated nanocarriers due to higher cellular binding. The TEM result also confirmed cellular internalization of DEX-SP-DOX-mAb magnetic nanocarriers. These results are very promising for targeted delivery of DOX to HER2 positive breast cancer cells.
Collapse
Affiliation(s)
- Shabnam Tarvirdipour
- Biomedical Division, Faculty of Chemical Engineering, Tarbiat Modares University, P.O. Box 14115-143, Tehran, Iran
| | - Ebrahim Vasheghani-Farahani
- Biomedical Division, Faculty of Chemical Engineering, Tarbiat Modares University, P.O. Box 14115-143, Tehran, Iran.
| | - Masoud Soleimani
- Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box 14115-331, Tehran,Iran
| | - Hassan Bardania
- Cell and Molecular research Center, Yasuj University of Medical Sciences, Yasuj, Iran
| |
Collapse
|
18
|
Ren X, Feng Y, Guo J, Wang H, Li Q, Yang J, Hao X, Lv J, Ma N, Li W. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications. Chem Soc Rev 2015; 44:5680-742. [DOI: 10.1039/c4cs00483c] [Citation(s) in RCA: 359] [Impact Index Per Article: 39.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
This review highlights the recent developments of surface modification and endothelialization of biomaterials in vascular tissue engineering applications.
Collapse
Affiliation(s)
- Xiangkui Ren
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
- Collaborative Innovation Center of Chemical Science and Chemical Engineering (Tianjin)
| | - Yakai Feng
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
- Collaborative Innovation Center of Chemical Science and Chemical Engineering (Tianjin)
| | - Jintang Guo
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
- Collaborative Innovation Center of Chemical Science and Chemical Engineering (Tianjin)
| | - Haixia Wang
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
| | - Qian Li
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
| | - Jing Yang
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
| | - Xuefang Hao
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
| | - Juan Lv
- School of Chemical Engineering and Technology
- Tianjin University
- Tianjin 300072
- China
| | - Nan Ma
- Institute of Chemistry and Biochemistry
- Free University of Berlin
- D-14195 Berlin
- Germany
| | - Wenzhong Li
- Department of Cardiac Surgery
- University of Rostock
- D-18057 Rostock
- Germany
| |
Collapse
|
19
|
Hosseinkhani H, Abedini F, Ou KL, Domb AJ. Polymers in gene therapy technology. POLYM ADVAN TECHNOL 2014. [DOI: 10.1002/pat.3432] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Hossein Hosseinkhani
- Graduate Institute of Biomedical Engineering; National Taiwan University of Science and Technology (Taiwan Tech); Taipei 10607 Taiwan
- Center of Excellence in Nanomedicine; National Taiwan University of Science and Technology (Taiwan Tech); Taipei 10607 Taiwan
- Research Center for Biomedical Devices and Prototyping Production, Research Center for Biomedical Implants and Microsurgery Devices, Graduate Institute of Biomedical Materials and Tissue Engineering, College of Oral Medicine, Taipei Medical University, Department of Dentistry; Taipei Medical University-Shuang Ho Hospital; Taipei 235 Taiwan
| | - Fatemeh Abedini
- Razi Vaccine and Serum Research Institute; Karaj Alborz IRAN
| | - Keng-Liang Ou
- Research Center for Biomedical Devices and Prototyping Production, Research Center for Biomedical Implants and Microsurgery Devices, Graduate Institute of Biomedical Materials and Tissue Engineering, College of Oral Medicine, Taipei Medical University, Department of Dentistry; Taipei Medical University-Shuang Ho Hospital; Taipei 235 Taiwan
| | - Abraham J. Domb
- Institute of Drug Research, The Center for Nanoscience and Nanotechnology, School of Pharmacy-Faculty of Medicine; The Hebrew University of Jerusalem; Jerusalem 91120 Israel
| |
Collapse
|